Uterus Cancer clinical trials at UC Cancer
1 research study open to eligible people
open to eligible people ages 56-81
The tumor stroma supports tumor growth, promotes tumor aggressiveness and metastatic potential. Stroma targeting approaches have become an attractive goal in research and industry. Braking the tumor stroma barrier may make tumor cells more accessible for pharmacologic, immunologic, radioactive or cell-based therapies.